|
1
|
Chiba T, Iwama A and Yokosuka O: Cancer
stem cells in hepatocellular carcinoma: Therapeutic implications
based on stem cell biology. Hepatol Res. 46:50–57. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Borggrefe T, Lauth M, Zwijsen A,
Huylebroeck D, Oswald F and Giaimo BD: The Notch intracellular
domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia
pathways. Biochim Biophys Acta. 1863:303–313. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takebe N, Miele L, Harris PJ, Jeong W,
Bando H, Kahn M, Yang SX and Ivy SP: Targeting Notch, Hedgehog, and
Wnt pathways in cancer stem cells: Clinical update. Nat Rev Clin
Oncol. 12:445–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yap LF, Lee D, Khairuddin A, Pairan MF,
Puspita B, Siar CH and Paterson IC: The opposing roles of NOTCH
signalling in head and neck cancer: A mini review. Oral Dis.
21:850–857. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gil-García B and Baladrón V: The complex
role of NOTCH receptors and their ligands in the development of
hepatoblastoma, cholangiocarcinoma and hepatocellular carcinoma.
Biol Cell. 108:29–40. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kongkavitoon P, Tangkijvanich P, Hirankarn
N and Palaga T: Hepatitis B virus HBx activates Notch signaling via
delta-like 4/Notch1 in hepatocellular carcinoma. PLoS One.
11:e01466962016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gao J, Xiong Y, Wang Y, Wang Y, Zheng G
and Xu H: Hepatitis B virus X protein activates Notch signaling by
its effects on Notch1 and Notch4 in human hepatocellular carcinoma.
Int J Oncol. 48:329–337. 2016.PubMed/NCBI
|
|
8
|
Sun Q, Wang R, Luo J, Wang P, Xiong S, Liu
M and Cheng B: Notch1 promotes hepatitis B virus X protein-induced
hepatocarcinogenesis via Wnt/β-catenin pathway. Int J Oncol.
45:1638–1648. 2014.PubMed/NCBI
|
|
9
|
Xu J, Yun X, Jiang J, Wei Y, Wu Y, Zhang
W, Liu Y, Wang W, Wen Y and Gu J: Hepatitis B virus X protein
blunts senescence-like growth arrest of human hepatocellular
carcinoma by reducing Notch1 cleavage. Hepatology. 52:142–154.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tian Q, Xue Y, Zheng W, Sun R, Ji W, Wang
X and An R: Overexpression of hypoxia-inducible factor 1α induces
migration and invasion through Notch signaling. Int J Oncol.
47:728–738. 2015.PubMed/NCBI
|
|
11
|
Pistollato F, Rampazzo E, Persano L,
Abbadi S, Frasson C, Denaro L, D'Avella D, Panchision DM, Puppa A
Della, Scienza R, et al: Interaction of hypoxia-inducible factor-1α
and Notch signaling regulates medulloblastoma precursor
proliferation and fate. Stem Cells. 28:1918–1929. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moriyama H, Moriyama M, Isshi H, Ishihara
S, Okura H, Ichinose A, Ozawa T, Matsuyama A and Hayakawa T: Role
of notch signaling in the maintenance of human mesenchymal stem
cells under hypoxic conditions. Stem Cells Dev. 23:2211–2224. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu JL, Liu LP, Yang SL, Fang X, Wen L, Ren
QG and Yu C: Hepatitis B virus induces hypoxia-inducible factor-2α
expression through hepatitis B virus X protein. Oncol Rep.
35:1443–1448. 2016.PubMed/NCBI
|
|
14
|
Gao J, Song Z, Chen Y, Xia L, Wang J, Fan
R, Du R, Zhang F, Hong L, Song J, et al: Deregulated expression of
Notch receptors in human hepatocellular carcinoma. Dig Liver Dis.
40:114–121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang SL, Yu C, Jiang JX, Liu LP, Fang X
and Wu C: Hepatitis B virus X protein disrupts the balance of the
expression of circadian rhythm genes in hepatocellular carcinoma.
Oncol Lett. 8:2715–2720. 2014.PubMed/NCBI
|
|
16
|
Zhou X, Teng L and Wang M: Distinct
prognostic values of four-Notch-receptor mRNA expression in ovarian
cancer. Tumour Biol. 37:6979–6985. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu J, Song F, Jin T, Qin J, Wu J, Wang M,
Wang Y and Liu J: Prognostic values of Notch receptors in breast
cancer. Tumour Biol. 37:1871–1877. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Q, Chen J, Liu L, Zhang J, Wang D, Ma
L, He Y, Liu Y, Liu Z and Wu J: The X protein of hepatitis B virus
inhibits apoptosis in hepatoma cells through enhancing the
methionine adenosyltransferase 2A gene expression and reducing
S-adenosylmethionine production. J Biol Chem. 286:17168–17180.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Previs RA, Coleman RL, Harris AL and Sood
AK: Molecular pathways: Translational and therapeutic implications
of the Notch signaling pathway in cancer. Clin Cancer Res.
21:955–961. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Villanueva A, Alsinet C, Yanger K, Hoshida
Y, Zong Y, Toffanin S, Rodriguez-Carunchio L, Solé M, Thung S,
Stanger BZ, et al: Notch signaling is activated in human
hepatocellular carcinoma and induces tumor formation in mice.
Gastroenterology. 143:1660–1669.e7. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang XQ, Zhang W, Lui EL, Zhu Y, Lu P, Yu
X, Sun J, Yang S, Poon RT and Fan ST: Notch1-Snail1-E-cadherin
pathway in metastatic hepatocellular carcinoma. Int J Cancer.
131:E163–E172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qi R, An H, Yu Y, Zhang M, Liu S, Xu H,
Guo Z, Cheng T and Cao X: Notch1 signaling inhibits growth of human
hepatocellular carcinoma through induction of cell cycle arrest and
apoptosis. Cancer Res. 63:8323–8329. 2003.PubMed/NCBI
|
|
23
|
Hayashi Y, Osanai M and Lee GH: NOTCH2
signaling confers immature morphology and aggressiveness in human
hepatocellular carcinoma cells. Oncol Rep. 34:1650–1658.
2015.PubMed/NCBI
|
|
24
|
Gramantieri L, Giovannini C, Lanzi A,
Chieco P, Ravaioli M, Venturi A, Grazi GL and Bolondi L: Aberrant
Notch3 and Notch4 expression in human hepatocellular carcinoma.
Liver Int. 27:997–1007. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu L, Xue F, Shao M, Deng A and Wei G:
Aberrant expression of Notch3 predicts poor survival for
hepatocellular carcinomas. Biosci Trends. 7:152–156.
2013.PubMed/NCBI
|
|
26
|
Ahn S, Hyeon J and Park CK: Notch1 and
Notch4 are markers for poor prognosis of hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int. 12:286–294. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang SL, Liu LP, Sun YF, Yang XR, Fan J,
Ren JW, Chen GG and Lai PB: Distinguished prognosis after
hepatectomy of HBV-related hepatocellular carcinoma with or without
cirrhosis: A long-term follow-up analysis. J Gastroenterol.
51:722–732. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Geng M, Xin X, Bi LQ, Zhou LT and Liu XH:
Molecular mechanism of hepatitis B virus X protein function in
hepatocarcinogenesis. World J Gastroenterol. 21:10732–10738. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin D and Wu J: Hypoxia inducible factor
in hepatocellular carcinoma: A therapeutic target. World J
Gastroenterol. 21:12171–12178. 2015. View Article : Google Scholar : PubMed/NCBI
|
